CollPlant Biotechnologies CLGN Cash Flow Statement (2017-2026)

NASDAQ CLGN
$3.61 +0.05 (+1.42%)
As of: Oct 20, 2026 · 11:11 AM EDT
Reported Financials

CollPlant Biotechnologies Quarterly Cash Flow Statement

Periods 35 quarters
Latest Jun 2026

CollPlant Biotechnologies reported cash from operations of -$2.33M and free cash flow of -$2.41M for the quarter ended Jun 2026, up 4.4% year over year. This cash flow statement covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
11.10M-3.77M-3.86M-4.29M-4.38M-4.40M-3.72M5.76M-4.38M-4.69M-4.20M-4.21M-4.33M-3.88M-1.45M-3.35M-3.48M-3.21M-3.10M-2.73M
Depreciation and DepletionDep. & Depletion
0.20M0.22M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.20M0.22M0.24M0.26M0.28M0.29M0.28M0.27M0.27M0.28M0.28M0.26M0.26M0.24M0.24M0.23M0.22M0.22M0.21M0.20M
Share-based CompensationStock Comp.
0.37M0.30M0.46M0.59M-0.68M0.48M0.51M0.34M-0.52M0.60M0.29M0.49M-0.52M0.43M0.38M0.36M-0.28M-0.01M0.18M0.17M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
-0.02M-0.13M0.09M-0.04M-0.52M0.28M0.35M-0.10M0.17M0.13M0.20M0.04M0.04M-0.06M0.04M0.27M-0.02M
Change in Working Capital
Change in ReceivablesChange Receivables
1.25M-1.26M0.27M-0.53M0.52M-0.52M-0.31M10.47M-10.15M-0.01M-0.09M0.34M-0.26M0.16M0.15M-0.30M0.29M-0.29M-0.01M0.02M
Change in InventoryChange Inventory
0.43M-0.29M-0.19M0.46M-0.32M0.36M-0.35M0.50M-0.26M-0.64M0.07M-0.35M0.55M-0.55M-0.23M0.34M-0.21M0.23M-0.10M0.07M
Change in Account PayablesChange Payables
0.17M0.17M-0.03M-0.24M0.12M0.25M-0.25M-0.12M-0.02M0.24M0.14M0.02M-0.13M-0.14M-0.10M-0.20M0.05M-0.01M0.03M-0.38M
Change in Accured ExpensesChange Accured Exp.
-0.63M0.47M-0.33M0.03M-0.16M0.48M0.07M-0.09M-0.10M0.33M0.06M-0.39M-0.05M0.03M-0.10M0.14M-0.11M0.02M-0.24M0.32M
Change in Other Operating AssetsOther Assets Change
-1.24M0.29M0.16M-0.21M-0.02M-0.28M0.12M-0.16M0.43M-1.06M0.14M-0.34M0.67M-1.08M0.17M-0.56M0.89M-1.37M0.18M-0.36M
Change in Other Operating LiabilitiesOther Liabilities Change
0.12M0.19M-0.20M-0.47M-0.13M-0.08M-0.22M-0.21M-0.23M0.03M-0.19M-0.21M-0.13M-0.12M-0.23M0.11M-0.13M-0.09M-0.18M-0.05M
Other Working Capital ChangesOther WC Changes
1.37M-0.10M-0.37M-0.26M-0.11M0.20M0.79M0.08M-0.66M1.10M0.05M0.58M-0.80M0.96M-0.39M0.67M-1.02M1.28M-0.36M0.31M
Cash from OperationsCash from Ops.
-2.82M-2.42M-3.21M-3.96M-3.19M-3.35M-3.45M-3.74M6.78M-2.35M-3.25M-3.93M-3.45M-3.46M-1.17M-2.44M-2.88M-2.94M-3.05M-2.33M
Investing Activities
Capital ExpendituresCapex
-1.34M2.40M-0.30M0.97M-1.67M2.26M-0.15M0.63M-1.21M1.68M-0.08M0.37M-0.71M0.91M-0.01M0.02M-0.03M0.04M-0.01M0.08M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M
Change in Property, Plant and EquipmentChange in PP&E
1.34M-2.40M0.30M-0.97M1.67M-2.26M0.15M-0.63M1.21M-1.68M0.08M-0.37M0.71M-0.91M0.01M-0.02M0.03M-0.04M0.01M-0.08M
Change in IntangiblesChange Intangibless
-0.19M0.27M-0.01M0.02M-0.04M0.07M
Purchase of InvestmentsInvestments Purchased
-60.00M60.00M-40.00M40.00M-0.12M0.33M-0.11M0.11M
Change in Acquisitions & DivestmentsChange Acquisitions
30.19M
Cash from Investing ActivitiesCash from Investing
9.37M-10.47M29.89M-0.34M-0.32M-0.30M-0.15M-0.40M-0.24M-0.37M-0.08M-0.26M-0.14M-0.06M-0.01M0.00M0.00M-0.02M-0.01M0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Short-Term Debt issuancesST Debt Issuance
-0.02M-0.15M-0.04M-0.05M-0.09M
Current Debt
-0.02M-0.15M-0.04M-0.05M-0.09M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.02M-0.15M-0.04M-0.05M-0.09M
Change in Capital Stock
Common Stock IssuedStock Issued
-31.00M0.19M1.47M0.40M0.80M0.09M0.22M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
-31.00M0.19M1.47M0.40M0.80M0.09M0.22M0.01M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
1.72M
Net Equity Issued and RepurchasedNet Equity Issued
-31.00M0.19M1.47M0.40M0.80M0.09M0.22M0.01M1.72M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
1.75M0.14M1.47M0.40M0.80M0.09M0.22M0.01M1.72M0.62M
Additional items
Exchange Rate EffectFX Effect
0.00M0.15M-0.23M-0.50M0.03M0.09M-0.28M-0.16M-0.13M0.20M0.13M-0.37M0.44M-0.34M0.01M0.07M-0.14M0.15M-0.01M0.05M
Change in Cash
8.31M-12.61M28.15M-5.02M-2.78M-3.86M-3.07M-4.21M6.62M-2.52M-3.45M-4.31M-3.55M-3.46M-1.17M0.70M-2.89M-2.96M-1.33M-1.70M
Ending Cash Balance
25.97M13.37M41.29M36.50M33.02M29.86M26.79M22.37M29.65M26.67M26.67M18.92M26.67M11.91M11.91M11.43M11.91M5.59M5.59M2.56M
Free Cash FlowFCF
-1.48M-4.82M-2.92M-4.93M-1.52M-5.61M-3.31M-4.37M7.98M-4.02M-3.17M-4.29M-2.74M-4.37M-1.16M-2.46M-2.85M-2.98M-3.04M-2.41M
Net Cash FlowNCF
8.30M-12.75M28.15M-4.29M-3.51M-3.25M-2.79M-4.05M6.75M-2.72M-3.33M-4.19M-3.59M-3.52M-1.18M-2.44M-2.88M-2.95M-1.34M-1.70M

CollPlant Biotechnologies Cash Flow Statement API

Pull CollPlant Biotechnologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLGN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY